Tissue factor (TF) antigen and activity were measured in leukemic cell homogenates. In leukemic cell homogenate, especially that of acute promyelocytic leuekmia (APL), both TF antigen and activity were significantly higher than these levels in the mononuclear cells obtained from healthy volunteers. Both TF antigen and activity were significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. In leukemic cell homogenates, there was a close correlation between TF antigen and TF activity. The TF activity/TF antigen ratio was significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. As the TF activity was not increased in lymphocytic leukemia cell homogenates to which were added phospholipids, the decrease in TF activity in lymphocytic leukemia might not be due to phospholipid in the leukemic cell membrane. Values for TF activity, TF antigen, and the TF activity/TF antigen ratio in leukemic cell homogenate from patients with disseminated intravascular coagulation (DIC) were significantly higher than those in patients without DIC. Therefore, the measurement of TF antigen and activity in leukemic cells could be useful for the prediction of DIC.
Summary: Tissue factor (TF) antigen and activity were measured in leukemic cell homogenates. In leukemic cell homogenate, especially that of acute promyelocytic leuekmia (APL), both TF antigen and activity were significantly higher than these levels in the mononuclear cells obtained from healthy volunteers. Both TF antigen and activity were significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. In leukemic cell homogenates, there was a close correlation between TF antigen and TF activity. The TF activity/TF antigen ratio was significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. As the TF activity was not increased in lymphocytic leukemia cell homogenates to which were added phospholipids, the decrease in TF activity in lymphocytic leukemia might not be due to phospholipid in the leukemic cell membrane. Values for TF activity, TF antigen, and the TF activity/TF antigen ratio in leukemic cell homogenate from patients with disseminated intravascular coagulation (DIC) were significantly higher than those in patients without DIC. Therefore, the measurement of TF antigen and activity in leukemic cells could be useful for the prediction of DIC. Key words: TF antigen&mdash;TF activity&mdash;Leukemic cell&mdash;DIC Most investigators agree that the dominant pathway of coagulation is the extrinsic pathway. This pathway is initiated when tissue factor (TF) binds to factor VII to form a l:l complex in the presence of calcium. As a potent initiator of coagulation, TF is believed to have a critical function in hemostasis and thrombogenesis (1) (2) (3) (4) . Physiologic and pathologic mediators can induce TF expression in monocytes and endothelial cells, suggesting an integral involvement of TF in the pathologic processes of inflammation and thrombogenesis (4) (5) (6) (7) .
In disseminated intravascular coagulation (DIC) (8-10), which is frequently associated with acute leukemia, DIC is considered to be caused by TF production in leukemic cells, as it has been shown that there is increased TF activity in leukemic cell lysates (11) . To elucidate the relationship between activity and antigen of TF, we examined both antigen and activity of TF in leukemic cell homogenates.
MATERIALS AND METHODS
We obtained leukemic cell homogenates from 97 leukemic patients-26 with acute myeloblastic leukemia (AML); 10 with acute promyelocytic leukemia (APL); 12 with acute myelomonocytic leukemia (AMMoL) and acute monocytic leukemia (AMoL); 11 with chronic myelocytic leukemia (CML); 10 with CML blastic crisis (CML, bc); 15 with acute lymphoblastic leukemia (ALL); 8 with chronic lymphocytic leukemia (CLL); and 5 with adult T cell leukemia (ATL). In 35 of these patients (10 with AML, 10 with APL, 5 with AMMoL and AmoL, 6 with ALL, and 4 with CML,bc), there was associated DIC. We also obtained mononuclear cells from 10 healthy volunteers. The diagnosis of DIC was based on the criteria established by the Japanese Ministry of Health and Welfare (Table 1)(12). Blood samples obtained from patients with more than 80% blast cells and from the healthy volunteers were drawn into tubes containing heparin. Three parts of the patients' heparinized blood were layered over seven parts of Ficoll-Hypaque (Pharmacia; Columbus, OH) and centrifuged for 30 minutes at 1,500 rpm. The blast cell fraction was recovered from the central layer, resuspended in 0.01 M phosphatebuffered saline, pH 7.4 (PBS), and washed more than five times with the same buffer. The contaminating red blood cells were hemolysed with 17 mM Tris-144 mM NH4C'21 pH 7.65. The leukemic cell suspension thus obtained (108 cells/ml in PBS) was freeze-thawed and sonicated for 2 minutes. Then, suspensions (20,000 g) were centrifuged for 30 minutes at 4°C, the cellular debris was removed, and the supernatant was stored at -80°C. Tissue factor antigen was measured by using the IMU-BIND Tissue Factor ELISA kit (American Diagnostica Inc.; Greenwich, CT). The test specimen was albumin and 0.05 % Tween 20 buffer, to eliminate the matrix effect of undiluted plasma. The monoclonal antibody in this kit was murine immunoglobulin G1 against tissue factor from human brain, detecting the TF-apoprotein complex, TF, and TF-FVII complex (13, 14) . TF activity was determined by using the method of Yvonne (15) . Fifty jjbl test samples were incubated for 120 minutes in 96-well plates with 25 >1 of 0.025 M CaCl2 and 25 >1 of 20 units/ml human coagulation factor IX complex (Christmassin-HT; Midori-Juji Co: Mbhldahl, Sweden) and 25 J.Ll of the chromogenic substrate S-2222 (Chromogenix AB). The change in optical density at 405 nm was increased with microplate reader. The TF activity was expressed as the amount of recombinant human TF protein standard (American Diagnostica Inc.; Greenwich, CT).
The effect of phospholipid on TF activity in leukemic cell homogenates was examined in APL, AML, ALL, and CLL. The TF activity in 25 jjbl of leukemic cell homogenates adding with 100 jjLM/25 ~1 of phosphatidylinositol, phosphatidylserine, or phosphatidylcholine (all three: Sigma Co.; St. Louis, MO) was assayed.
Values are expressed as mean ±standard deviation and the significance of differences between two groups was assessed by students' t-tests.
RESULTS
The levels of TF antigen in mononuclear cells from normal volunteers was 53.5 ± 12.2 pg/10~ cells; the level was significantly increased in the leukemic homogenate in APL (946.2±427.9 pg/ 107 cells), and slightly increased in AML (100.5±67.3 pg/10~ cells), AMMoL and AmoL (99.3 ± 85.9 pg/107 cells), ALL (108.5±35.7 pg/ 107 cells), CLL (69.6±17.7 pgl 107 cells), and ATL (105±22.9 pg/10~ cells). TF antigen in leukemic cell homogenate in CML,bc (85.5±55.3 pg/10~ cells) was significantly higher than that in CML (29.6±2.9 pg/107 cells). TF antigen was significantly higher in myelocytic leukemia than in lymphocytic leukemia cells (p< 0.05) (Fig. 1 ). TF activity in mononuclear cells from normal volunteers was 30.0±10.0 pg/107 cells; it was significantly increased in the leukemic homogenates of APL (904.7± 400.1 pg/107 cells) and slightly increased in AML (52.0±53.9 pg/107 cells), AMMoL and AMoL (54.3±66.4 pg/107 cells), ALL (17.4±16.6 pg/107 cells), CLL (3.1±2.4 pg/107 cells), and ATL (1.1±0.3 pg/107 cells). TF activity in leukemic cell homogenate in CML,bc (68.8±59.4 pg/10' cells) was significantly higher than that in CML (19.6±13.1 pg/107 cells)(p< 0.05) (Fig. 2 ). In leukemic cell homogenates, there was a close correlation between TF antigen and TF activity (r = 0.975, p< 0.01 ) (Fig. 3 ). The ratio of TF activity/TF antigen in mononuclear cells from normal volunteers was 0.56 ±0.09; it was significantly increased in the leukemic cell homogenates in APL (0.97±0.13). In leukemic cells from CML,bc this ratio was similar to that in cells from CML, but it was significantly higher in myelocytic leukemia than in lymphocytic leukemic cells ( Fig. 4 ) (P< 0.01). In the leukemic cells of patients with DIC, TF activity, TF antigen, and the ratio of TF activity/ TF antigen were significantly higher than those in the leukemic cells of patients without DIC (Fig. 5 ).
DISCUSSION
Although TF is considered to be the main initiator in the events that produce DIC, plasma TF antigen was ' detected not only in DIC patients but also in normal volunteers (16) . Because TF antigen was not detected in unstimulated platelets or leukocytes, it was suggested that plasma TF antigen was physiologically released from locally stimulated monocytes or endothelial cells (16) . In endothelial cells is enhanced by the addition of endotoxin or various cytokines (17, 18) . In sepsis and solid cancer, elevated plasma cytokines levels have been reported (19, 20) , and these elevated cytokines might increase TF synthesis by monocytes and vascular endothelial cells. Here, we found that in acute leukemia, TF antigen in leukemic cell homogenate, especially in APL, was significantly higher than in mononuclear cells from normal volunteers. It was reported that TF antigen existed on the surface of leukemic cell (21) . TF antigen was also significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. The plasma TF antigen in DIC patients with AML has been shown to be higher than that in those with ALL (16) . In DIC associated with leukemia, plasma TF is thought to be produced by the leukemic cells. TF activity was also increased in leukemic cell homogenates. In leukemic cell homogenates, we found a close correlation between TF antigen and TF activity. The ratio of TF activity/TF antigen in mononuclear cells from normal volunteers was about 0.56; however, it was significantly increased in the leukemic cell homogenates of APL and was significantly higher in myelocytic leukemia than in lymphocytic leukemia cells. As the addition of phospholipids did not significantly increase the TF activity in leukemic cell homogenates, the decrease in TF activity in lymphocytic leukemia might not be due to phospholipids in the leukemic cell membrane. These results suggest that low specific activity of TF is produced in lymphocytic leukemic cells or that TF activity in lymphocytic leukemia cells is destroyed after production. TF antigen in leulemic cell homogenate in CML,bc was significantly higher than that in CML, whereas the ratio of TF activity/TF antigen in leukemic cells from CML,bc was similar to that in leukemic cells from CML, suggesting that the change of TF in leukemic cells by blastic crisis might be increased quantity of TF. The measurement of TF antigen in leuekmic cells might be useful for the diagnosis of blastic crisis such as plasminogen activator and plasminogen activator inhibitor (22) . Because values for TF activity, TF antigen, and the ratio of TF activity/TF antigen in leukemic cells from patients with DIC were significantly higher than those in patients without DIC, the measurement of both TF activity and TF antigen in leukemic cells could be useful for the prediction of DIC, as reported previously (11) .
